Protagonist Therapeutics (PTGX) PT Lowered to $33 at H.C. Wainwright

November 10, 2022 6:48 AM EST Send to a Friend

H.C. Wainwright analyst Douglas Tsao ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Protagonist Therapeutics (PTGX) PT Lowered to $33 at H.C. Wainwright

Member Login

Free News Feed